CIST - Bluestone renewal.
This is not very informative beyond the headline.
John de C
Cistron Biotechnology Extends Agreement With BlueStone Capital Partners
PINE BROOK, N.J., March 31 /PRNewswire/ -- Cistron Biotechnology, Inc. (OTC: CIST - news) has renewed its agreement with BlueStone Capital Partners, L.P., New York-based investment banking firm, for another six months it was announced today.
''Since September, 1997 Cistron and BlueStone have worked closely together in several areas including corporate strategic partnering with the goal of enhancing shareholder value. Today's contract extension enables us to continue our efforts,'' stated Bruce C. Galton, Cistron's acting chief executive officer.
Robert W. Naismith, Ph.D., BlueStone's managing director of healthcare, was elected to Cistron's board of directors in January, 1998. |
